This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Service
Reference
Merck KGaA, et al. NICE Positive Recommendation Supports Use of Bavencio(R)(Avelumab) for Treatment of Adults in England, Wales and Northern Ireland with Metastatic Merkel Cell Carcinoma, a Rare Skin Cancer. Media Release : 1 Mar 2018. Available from: URL: http://www.merckgroup.com
Rights and permissions
About this article
Cite this article
NICE recommends avelumab for metastatic Merkel cell carcinoma. PharmacoEcon Outcomes News 798, 34 (2018). https://doi.org/10.1007/s40274-018-4781-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4781-x